Lyxor said in its Weekly Brief that the firm is positioned around three axes to begin 2019: reduce exposure to high beta strategies, reduce sensitivity to Momentum, and leverage on the U.S. M&A cycle.

Overall, alternative strategies appear attractive but dispersion across strategies might be high, said Lyxor's Cross Asset Research team.

The dominance of specu